Mucormycosis in a liver allograft: Salvage re-transplantation and targeted immunosuppressive management

Transplant Infectious Disease

Volumn 14, Issue 5, 2012, Pages

  Gurevich, M ^a   Levi, I ^b   Steinberg, R ^b   Shonfeld, T ^b   Shapiro, R ^b   Israeli, M ^a   Sprecher, H ^c   Shalit, I ^b   Mor, E ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c Clinical Microbiology Laboratory   (Israel)

Author keywords

Antifungal therapy; Immune monitoring; Liver abscess; Liver transplantation; Mucormycosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; STEROID; TACROLIMUS; VANCOMYCIN; VORICONAZOLE;

ALLOGRAFT; ANASTOMOSIS LEAKAGE; ARTICLE; ASSAY; BILE LEAKAGE; CANDIDA KRUSEI; CASE REPORT; CD4+ T LYMPHOCYTE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; GASTRECTOMY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER ABSCESS; LIVER BIOPSY; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MUCORMYCOSIS; ORGAN TRANSPLANTATION; PATIENT MONITORING; PERICARDIAL EFFUSION; PERITONEAL FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REOPERATION; RHIZOPUS ORYZAE; SPLEEN INFARCTION; SPLENECTOMY; THORACOTOMY;

ANTIFUNGAL AGENTS; CHILD; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MUCORMYCOSIS; RHIZOPUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867654507     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00776.x     Document Type: Article

References (18)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13 (2): 236-301.
2. Miguélez M, Lumbreras C, Herrero JA, et al. Invasive fungal infections in liver transplant recipients: analysis of 21 cases. Med Clin 1998; 110 (11): 406-410.
3. Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis 2002; 4 (Suppl 3): 18-23.
4. Chkhotua A, Yussim A, Tovar A, et al. Mucormycosis of the graft in a renal transplant recipient: case report and review of the literature. Transpl Int 2001; 14 (6): 438-441.
5. Zhan HX, Lv Y, Zhang Y, et al. Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: a case report. Transplant Proc 2008; 40 (5): 1771-1773.
6. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006; 6 (10): 2365-2374.
7. Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008; 61 (Suppl 1): i35-i40.
8. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using immune function assay. Transplantation 2006; 82 (5): 663-668.
9. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17 (2): 77-88.
10. Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005; 58 (11): 1180-1184.
11. Rabkin JM, Oroloff SL, Corless CL, et al. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 2000; 179 (5): 426-430.
12. Busca A, Marmont F, Locatelli F, et al. Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic mucormycosis in a patient with haematological malignancy. Mycoses 2010; 53 (3): 275-278.
13. Marcó del Pont J, De Cicco L, Gallo G, Llera J, De Santibanez E, D'agostino D. Hepatic arterial thrombosis due to Mucor species in a child following orthotopic liver transplantation. Transpl Infect Dis 2000; 2 (1): 33-35.
14. Spellberg B, Ibrahim A, Roilides E, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 2012; 1: S73-S78.
15. Ballester F, Pastor FJ, Guarro J. In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus. J Antimicrob Chemother 2008; 61 (3): 755-757.
16. Greenberg RN, Mullane K, van Burik JAH, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126-133.
17. Rickerts V, Atta J, Herrmann S, et al. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukemia. Mycosis 2006; 49 (Suppl 1): 27-30.
18. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008; 47(3): 364-371.